Skip to content

Inogen INGN Operating Lease Right-of-Use Assets in Other Assets

Operating Lease Right-of-Use Assets in Other Assets at other companies

ResMed logo
ResMedRMD
AdaptHealth logo
AdaptHealthAHCO
Viemed Healthcare, Inc. logo
Viemed Healthcare, Inc.VMD
Pulmonx Corporation logo
Pulmonx CorporationLUNG
Tactile Systems Technology logo
Tactile Systems TechnologyTCMD
iRhythm Holdings, Inc.
 logo
iRhythm Holdings, Inc. IRTC

Other financials

Income statement

See full
Revenue$85.1M+3.4%
Gross profit$44.9M+1.7%
Operating income-$9.3M-21.9%
Net income-$8.3M-34.8%
EPS (diluted)-$0.30-20.0%

Balance sheet

See full
Cash & equivalents$93.1M-21.7%
Total debt$16.9M-11.9%
Total equity$182.9M-7.6%
Total assets$285.9M-7.3%

Cash flow

See full
Operating cash flow-$6.7M+60.2%
CapEx$210.0K-28.1%
Free cash flow-$6.9M+59.6%

Valuation

See full
Market cap$174.63M-9.7%
Enterprise value$98.45M-9.5%
P/S0.5×-0.1×

Profitability

See full
Gross margin52.8%-2.6pp
Operating margin-9.1%-0.8pp
Net margin-7.1%-0.8pp
FCF margin0.4%

Returns & leverage

See full
Return on equity-13.1%-0.9pp
Debt / equity0.1×0.0×
Current ratio3.1×0.0×

Where this comes from

Reported directly by Inogen in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Inogen’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Inogen's operating lease right-of-use assets in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Inogen's operating lease right-of-use assets in other assets?
Inogen (INGN) reported operating lease right-of-use assets in other assets of $15.73M in Q1 2026.
How has Inogen's operating lease right-of-use assets in other assets changed year-over-year?
Inogen's operating lease right-of-use assets in other assets decreased by 13.2% year-over-year, from $18.12M to $15.73M.
What is the long-term trend for Inogen's operating lease right-of-use assets in other assets?
Over 5 years (2020 to 2025), Inogen's operating lease right-of-use assets in other assets has grown at a 13.3% compound annual growth rate (CAGR), from $8.83M to $16.5M.